NCT05544448Completed🇫🇷 With a site in France
In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Participants (registry)
- 67
- Start
- October 2023
- Primary completion
- June 2024
- Study completion
- June 2024
- Last registry update
- February 2026
- Countries
- France
Conditions studied: Autoimmune Diseases, Inflammatory Disease, Acquired Bone Marrow Aplasia, Systemic Lupus Erythematosus, Multiple Sclerosis, Gvhd, Rheumatoid Arthritis, Autoimmune Thyroiditis, Vitiligo, Alopecia, Atopic Dermatitis
Interventions: Blood sample taken at a single time point
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.